- Report
- October 2024
- 198 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- July 2024
- 150 Pages
Global
From €5640EUR$5,950USD£4,711GBP
- Report
- July 2024
- 136 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- April 2025
- 173 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- July 2024
- 182 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- January 2024
- 210 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- October 2023
- 506 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- February 2022
- 379 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- February 2024
- 120 Pages
United Kingdom
From €4502EUR$4,750USD£3,761GBP
- Report
- February 2024
- 120 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- December 2023
- 250 Pages
Global
€4734EUR$4,995USD£3,955GBP
The Veterinary Molecular Diagnostic market is a subset of the Animal Healthcare/Veterinary industry. It focuses on the use of molecular diagnostics to detect and diagnose diseases in animals. This includes the use of genetic testing, PCR testing, and other molecular techniques to identify and monitor diseases in animals. Veterinary Molecular Diagnostics can be used to detect and diagnose a wide range of diseases, including infectious diseases, genetic disorders, and cancer. It can also be used to monitor the effectiveness of treatments and to identify drug resistance.
The Veterinary Molecular Diagnostic market is growing rapidly, driven by the increasing demand for animal healthcare services and the need for more accurate and reliable diagnostic tests. This market is expected to continue to grow in the coming years, as more advanced technologies become available.
Some companies in the Veterinary Molecular Diagnostic market include IDEXX Laboratories, Inc., Neogen Corporation, Abaxis, Inc., and Zoetis, Inc. Show Less Read more